All posts in Valuations & Financial Modelling

14 May

Independent Valuation Report – Listing Rule 7.1A.3

SLM advises that it has completed an Independent Valuation Report for ASX Listed Elixinol Global Limited (ASX EXL).

Under Australian Securities Exchange (“ASX”) Listing Rule 7.1A.3 where equity securities are issued for non-cash consideration (i.e. the acquisition of an asset), the eligible entity must provide for release to the market a valuation of the non-cash consideration that demonstrates that the issue price of the securities complies with the Listing Rule 7.1A.3.  The rule requires that the eligible entity must demonstrate that the deemed issue price of the securities issued in consideration for the acquisition of the asset is no lower than 75% of the volume weighted average share price (“VWAP”) of the securities over the 15 days during which trades in the securities were recorded immediately before the securities are issued.

A copy of the report can be found here: https://www.asx.com.au/asxpdf/20190424/pdf/444hwsnrxq07rr.pdf

For further information, please contact Barry Lewin or Kuo ning Ho from SLM Corporate on 03 9244 9644.

21 Oct

A busy period at SLM for valuations

The past few months have been a busy time for valuations at SLM.

We have recently completed Independent Expert Reports for Australian Natural Proteins Limited, Cellmid Limited and Immune System Therapeutics Limited.  We have also valued options and performance rights for shareholders voting on director remuneration, for the accounting treatment of share based payments, and for several executive reward schemes.

For further information, please contact Barry Lewin, SLM Corporate Managing Director on 03 9244 9644.

17 Apr

SLM completes Independent Expert Report for Anittel Group Limited

In Important,Valuations & Financial Modelling by chopsky / April 17, 2012 / 0 Comments

SLM is pleased to announce that it has completed an independent expert report for Anittel Group Limited (ASX: AYG), for the purposes of item 7 of section 611 of the Corporations Act. Anittel’s general meeting will be held on 24 May 2012.

For further information, please contact:

Barry Lewin
Managing Director
SLM Corporate
Ph: (03) 9244 9644
Email: barry.lewin@slmcorporate.com.au

28 Feb

SLM completes valuation of key intellectual property and operating assets for Consegna Group Limited

In Valuations & Financial Modelling by chopsky / February 28, 2012 / 0 Comments

SLM is pleased to advise that its valuation team has valued key intellectual property and operating assets for innovative medical technology company Consegna Group Limited (ASX: CGP). Consegna is focused on the commercialisation of a range of thereapeutic drug delivery technologies. The independent valuation was sought by the Board for the purposes of impairment testing related to the company’s financial reporting obligations.

For further information, please contact:

Barry Lewin
Managing Director
SLM Corporate
03 9244 9644
email: barry.lewin@slmcorporate.com.au

-->